CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 50  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0894
LYS 10.0701
GLU 20.0517
LEU 30.0486
ARG 40.0511
CYS 50.0220
GLN 60.0075
CYS 70.0102
ILE 80.0357
LYS 90.0138
THR 100.0090
TYR 110.0162
SER 120.0131
LYS 130.0130
PRO 140.0013
PHE 150.0279
HIS 160.0626
PRO 170.0164
LYS 180.0158
PHE 190.0103
ILE 200.0111
LYS 210.0137
GLU 220.0138
LEU 230.0090
ARG 240.0160
VAL 250.0201
ILE 260.0162
GLU 270.0193
SER 280.0121
GLY 290.0563
PRO 300.0352
HIS 310.0251
CYS 320.0182
ALA 330.0129
ASN 340.0127
THR 350.0132
GLU 360.0062
ILE 370.0057
ILE 380.0052
VAL 390.0055
LYS 400.0099
LEU 410.0106
SER 420.0090
ASP 430.0155
GLY 440.0044
ARG 450.0165
GLU 460.0045
LEU 470.0075
CYS 480.0077
LEU 490.0058
ASP 500.0127
PRO 510.0095
LYS 520.0205
GLU 530.0147
ASN 540.0138
TRP 550.0160
VAL 560.0101
GLN 570.0073
ARG 580.0267
VAL 590.0135
VAL 600.0089
GLU 610.0113
LYS 620.0122
PHE 630.0042
LEU 640.0186
LYS 650.0239
ARG 660.0328
ALA 670.0608
GLU 680.0496
ASN 690.0894

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.